GE Medical Systems is set to commercialize its Signa Profile openMRI scanner after receiving Food and Drug Administration clearancefor the system last month. The Milwaukee vendor introduced the0.2-tesla scanner at last year's Radiological Society of
GE Medical Systems is set to commercialize its Signa Profile openMRI scanner after receiving Food and Drug Administration clearancefor the system last month. The Milwaukee vendor introduced the0.2-tesla scanner at last year's Radiological Society of NorthAmerica meeting (SCAN 12/28/94).
Can a Deep Learning Algorithm Enhance Detection of Prostate Cancer Recurrence with Biparametric MRI?
September 26th 2023For patients who had previous radiotherapy for prostate cancer (PCa), researchers found that a biparametric MRI-based deep learning model demonstrated an 81.5 percent sensitivity rate for PCa recurrence in patients previously treated with external beam radiation treatment (EBRT) and 100 percent sensitivity in patients with greater than 34 ml in gland volumes.
2 Clarke Drive
Cranbury, NJ 08512